SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001437749-20-020364
Filing Date
2020-09-28
Accepted
2020-09-28 16:56:01
Documents
12

Document Format Files

Seq Description Document Type Size
1 FORM 424B4 govx20200927_424b4.htm 424B4 1910179
2 govx20200927_424b4img001.jpg GRAPHIC 7877
3 govx20200927_424b4img002.jpg GRAPHIC 8956
4 govx20200927_424b4img003.gif GRAPHIC 13890
5 govx20200927_424b4img004.jpg GRAPHIC 9128
6 govx20200927_424b4img005.gif GRAPHIC 13611
7 govx20200927_424b4img006.jpg GRAPHIC 2197
8 govx20200927_424b4img007.jpg GRAPHIC 2336
9 govx20200927_424b4img008.jpg GRAPHIC 6837
10 govx20200927_424b4img009.jpg GRAPHIC 2841
11 govx20200927_424b4img010.gif GRAPHIC 5359
12 govx20200927_424b4img011.jpg GRAPHIC 4953
  Complete submission text file 0001437749-20-020364.txt   2020471
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-239958 | Film No.: 201205138
SIC: 2834 Pharmaceutical Preparations